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Effect of Resveratrol on periodontal 
pathogens during experimental 
periodontitis in rats
Abstract: The objective of this study was to investigate the antibacterial 
effect of resveratrol against putative periodontal pathogens during the 
progression of experimental periodontitis in rats. Periodontitis was 
induced in rats in one of the first molars chosen to receive a ligature. 
Animals were assigned to one of two groups: daily administration of 
the placebo solution (control group, n = 12) or 10 mg/Kg of resveratrol 
(RESV group, n = 12). The therapies were administered systemically for 
30 days, for 19 days before periodontitis induction and then for another 
11 days. Then, the presence and concentrations of Porphyromonas 
gingivalis, Tannerella forsythia and Aggregatibacter actinomycetemcomitans 
in the cotton ligatures collected from the first molars were evaluated 
using real-time PCR. Inter-group comparisons of the microbiological 
outcomes revealed that no differences were detected for P. gingivalis, 
T. forsythia and A. actinomycetemcomitans levels (p > 0.05). Continuous 
use of resveratrol did not promote additional benefits in microbiological 
outcomes during experimental periodontitis in rats.
Keywords: resveratrol; periodontitis; alveolar bone loss; 
anti-inflammatory agents; anti-bacterial agents.
Introduction
Periodontitis is a major chronic inflammatory disease that is the 
most prevalent form of bone pathology in humans with up to 15% of 
the adult population affected by severe periodontitis at some point in 
their lives.1 This disease is characterized by an infection that leads to 
the occurrence of the destruction of the supporting tissue and induces 
a local production of immune-inflammatory mediators in response to 
periodontal pathogens and their products.2 Although the nature of 
host immune-inflammatory responses to microbiota may motivate the 
pathology that is observed, the existence of one or more microorganisms 
that are considered to be a periodontal pathogen in sufficient numbers 
is needed to establish periodontitis.3 Key periodontopathic bacteria, 
such as Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf) and 
Aggregatibacter actinomycetemcomitans (Aa), are related to the beginning 
of periodontal disease and may prolong imbalance in the microbiota 
and the host response in periodontal tissues, which encourages the 
development of periodontitis.2,4,5 Thus, although there is a consensus 
that the response of the host against bacterial challenge is essential 
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for the development of the disease, the specific 
etiological agent of periodontal disease is bacterial 
biofilm, which has been confirmed by experimental 
and human studies.4,6
The compound resveratrol (3,5,4’-trihydroxystilbene) 
is a polyphenol present in many plant species that 
are used for human consumption, particularly 
grapes and red wine.7 It has been shown by the 
scientific community that resveratrol has potent 
antioxidant, antitumor and anti-inflammatory 
effects that benefit the treatment of some diseases, 
such as cancer, diabetes, cardiovascular disorders, 
degenerative diseases, autoimmune diseases and 
metabolic diseases.8,9,10,11,12
The impact of the use of resveratrol on the 
immune-inflammatory system is closely linked 
to its antioxidant capacity and anti-inflammatory 
activity.11,13,14,15,16 However, some studies have 
also indicated that resveratrol has significant 
ant imicrobial ef fects in dist inct in fect ious 
circumstances.17,18,19,20,21 As related to periodontitis, 
a study by O’Connor et al.18 demonstrated the 
effect of resveratrol in vitro on the inhibition 
of periodontal A. actinomycetemcomitans and P. 
gingivalis. Park et al.17 also showed that resveratrol 
attenuated P. gingivalis LPS-induced monocyte 
adhesion to the endothelium, which suggested it has 
a therapeutic role in periodontal pathogen-induced 
vascular inflammation. 
Due to the potential benefits of resveratrol for 
controlling periodontal disease15,22 and taking into 
account its antimicrobial ability in different types of 
infectious diseases,19,20,21 the aim of this investigation 
was to determine the antibacterial effects of resveratrol 
against putative periodontal pathogens in a rat 
experimental periodontitis model.
Methodology
Animals
This study used male Wistar rats that were 10 weeks 
old and that weighed 308 ± 35 g at the beginning of 
the study. The rats were obtained from the Butantan 
Institute in São Paulo, Brazil. The rats were acclimatized 
for 15 days before they were used, and they were kept 
in temperature-controlled cages that were exposed 
to a 24-h light–dark cycle with equal light and dark 
time; the animals had free access to water and food ad 
libitum and were housed at the Bioterium of Paulista 
University (Labina, Purina1, Paulinia, SP, Brazil). 
The experimental procedure was approved by the 
Paulista University Institutional Animal Care and 
Use Committee (060/11 CEP/ICS/UNIP). 
Study design and treatment groups
The study design and treatment groups were 
previously described in detail.16 Briefly, animals 
were assigned to one of two groups: a control 
group (n = 12) that received daily administration 
of a placebo solution for 30 days, or the RESV 
Group (n = 12) that received daily administration of 
10 mg/kg of resveratrol for 30 days. A stock solution 
of resveratrol (R5010-500MG – Sigma-Aldrich Ltda, 
São Paulo, Brazil) (molecular weight: 228.2)) was 
prepared in ethanol and further diluted in water to 
working concentrations. The placebo solution was 
composed of the same quantities of ethanol and 
water that were used in preparing the resveratrol. 
The therapies were administered via gavage by a 
blinded researcher for 30 days - for 19 days before 
periodontitis induction and for another 11 days 
following ligature placement. Figure illustrates the 
study design.
Figure. Schematic illustration of the study design.
Day-19
Beginning of the daily
administration of the
treatments
Day 0
Periodontitis induction
Day 11
Euthanasia
The therapies were administered via gavage for 30 days
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Rat periodontitis model
To induce experimental periodontitis, one of the 
mandibular first molars of each animal was randomly 
assigned to receive a cotton ligature (Corrente Algodão 
no. 10; Coats Corrente, São Paulo, Brazil) that was knotted 
submarginally in a cervical position. The ligatures were 
kept in position to allow biofilm accumulation over 11 
days.23 The contralateral tooth was left unligated so that 
it could be used as a control for alveolar bone loss. This 
procedure was performed under general anesthesia by 
intramuscular administration of 0.5 mL/kg ketamine 
hydrochloride (Dopalen®, Agribrands Brasil Ltda., 
Paulínia, Brazil) and 10 mg/kg xylazine hydrochloride 
(Rompun®, Bayer S.A., São Paulo, Brazil).
The animals were evaluated daily throughout 
the experiment to check for possible clinical or 
toxicological symptoms. Thirty days after the start 
of the study, the animals were euthanized by CO2 
inhalation. The cotton ligatures were collected from 
the 1st molar from each rat for microbiological analysis. 
The morphometric analysis of bone loss and 
immuno-enzymatic assay of the gingival tissue have 
been previously described in detail.15
Microbiological evaluation 
Cotton ligatures were collected from the 1st molar of 
each rat and then were placed into sterile tubes containing 
300 μL of 0.5 mM Tris-EDTA. DNA was extracted from 
each sample using a commercially available kit (QIAamp 
Genomic DNA Extraction, Qiagen).
The presence percentage of positive sites and 
the concentration of P. gingivalis, T. forsythia and A. 
actinomycetemcomitans were evaluated by real-time PCR 
using specific primers reported in the literature by a 
previous researcher.24,25 Initially, DNA was extracted from 
the subgingival biofilm. Real-time PCR was performed 
using the FastStart DNA Master SYBR Green I kit. The 
concentration of the DNA used in each run was 10 μg/
ml. The amplification profiles were as follows: 95°/10 ,` 
55°/5 ,` 72°/4` , 40 cycles for Pg; 95°/10 ,` 55°/5 ,` 72°/3` and 40 
cycles for Aa. Absolute quantification of target bacteria 
in clinical samples was performed using Pg (ATCC 
33277) and Aa (JP2) as controls. The determination of 
DNA genome copies in the controls was based on the 
genome size of each bacteria and the mean weight of one 
nucleotide pair with a minimum detection level of 103 
cells. The examiners that performed the microbiological 
evaluations were blinded to the experimental groups.
Statistical analysis
To test the null hypothesis that resveratrol 
had no influence on periodontal pathogens levels, 
intergroup analysis of the concentration of each 
bacteria was performed by unpaired Student’s t-test, 
and comparisons between the groups of the percentage 
of sites that were positive for periodontal pathogens 
were performed using the Chi-square test. The 
significance level established for all analyses was 5%. 
Results
For the microbiological outcomes observed in 
this study, the inter-group comparisons revealed 
that there was no difference between groups for 
Aa, Pg or Tf levels (p > 0.05). Similar results were 
observed regarding with the percentage of sites that 
were positive for these bacteria after therapy, and 
there were no differences between groups (p > 0.05). 
Tables 1 and 2 show the concentration (log[ ]) and the 
frequency (%), respectively, of each of the periodontal 
pathogens that were tested.
Table 1. Mean ± standard deviation of the concentration 
(log [ ]) of the periodontal pathogens Aggregatibacter 
actinomycetemcomitans Aa, Porphyromonas gingivalis Pg and 
Tannerella forsythia Tf in ligatures from the control and RESV groups.
Variable Aa Pg Tf
Control [% (n)] 6.6 ± 1.0 2.4 ± 2.4 2.1 ± 2.4
RESV  [% (n)] 5.4 ± 1.8 1.5 ± 2.2 1.5 ± 2.1
p-value 0.08 0.39 0.53
Student t test p > 0.05
Table 2. Percentage (%) and absolute number (n) of sites positive for 
the periodontal pathogens Aggregatibacter actinomycetemcomitans 
Aa, Porphyromonas gingivalis Pg and Tannerella forsythia Tf in 
ligatures from the control and RESV groups.
Variable Aa Pg Tf
Control [% (n)] 83.3 (10) 50.0 (6) 41.7 (5)
RESV  [% (n)] 91.7 (11) 33.3 (4) 33.3 (4)
p-value 0.54 0.41 0.67
Chi-squared test p  > 0.05.
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Discussion
Some evidence suggests that resveratrol may 
have antibacterial potential, including against 
periodontitis-associated bacteria species.17,18 However, 
until now, no in vivo study has examined the influence 
of this substance on periodontal pathogens in sites 
presenting with periodontal breakdown. The 
present study, which used quantitative analyses and 
real-time PCR, represented an effort to determine the 
actual impact of resveratrol on the bacterial load of 
periodontal-related species during the progression 
of experimental periodontitis in rats. 
In the current investigation, the animals did 
not show any signs of systemic illness throughout 
the study period. The rats also did not lose weight 
throughout the experimental period, and no deaths 
were observed. Inter-group comparisons of the 
morphometric results revealed higher bone-loss 
values in ligated molars and unligated teeth in the 
control group than the RESV group (p < 0.05)15. 
Concerning the microbiological outcomes observed 
in this study, inter-group comparisons revealed that 
no difference between groups was detected for Aa, 
Pg or Tf levels (p > 0.05). Similar results were observed 
regarding the percentage of sites positive for these 
bacteria after therapy, and there were no differences 
between groups (p > 0.05). Thus, the findings of 
this investigation revealed that this natural plant 
compound did not promote additional benefits in 
terms of pathogen reduction in sites presenting with 
induced periodontal disease. 
Previous studies have reported that resveratrol 
provides important antimicrobial actions, including 
antiviral, antifungal, antiprotozoal, and antibacterial 
activities.26,27,28,29 When the antimicrobial effect of 
resveratrol on the growth of periodontal pathogens was 
analyzed, O’Connor et al.18 showed in vitro that this agent 
inhibited the anaerobic bacteria Aa and Pg in a similar 
time-dependent manner. Although the microbiological 
data of the current study have not demonstrated that 
this medicinal plant significantly interfered with the 
decrease of putative periodontopathogens, a trend 
toward the reduction of A. actinomycetemcomitans was 
observed in rats treated with resveratrol (p = 0.08) 
(Table 1). To the best of our knowledge, this is the first 
experimental study to investigate the antibacterial impact 
of resveratrol in pathogens related to periodontitis, which 
prevents a more direct comparison to the outcomes 
from other investigations.
Importantly, previous studies demonstrated that 
susceptibility to resveratrol may be different among 
bacteria, and this agent may present different antibacterial 
mechanisms of action according to the microorganism by 
exerting either a bacteriostatic or bactericidal effect.19,30,31,32,33 
Indeed, although the study by O’Connor et al.18 had 
reported promising effects of resveratrol against anaerobic 
bacteria, its outcomes did not demonstrate encouraging 
results when aerobic microorganisms were evaluated. 
According to the authors, it is possible that the antioxidant 
properties of resveratrol inhibit the metabolic pathways of 
the bacteria that are mandatory for anaerobic survival.18 
However, additional investigations are required to 
support this hypothesis. 
It is important to highlight that the current study 
evaluated the antimicrobial ability of resveratrol on 
the periodontitis-associated species during biofilm 
formation and not in in vitro experiments, which may 
explain differences in the observed results when they are 
compared with the findings of O’Connor et al.,18 which 
could be considered more similar to clinical conditions. 
Interestingly, the periodontopathic bacteria studied in 
the present study were responsible for the initiation of 
periodontal disease and may perpetuate the imbalance 
in the microbiota and the host inflammatory response 
in periodontal tissues to stimulate the progression of 
periodontitis.4 Similar to human periodontitis, bacterial 
penetration of the host tissue is thought to be a crucial 
factor affecting alveolar bone loss in rats. Rovin et al.34 
assessed the influence of bacteria and their antigens on 
the beginning of periodontal disease in germ-free and 
conventional rats, and they showed that microorganisms 
were necessary for the occurrence of inflammatory 
periodontal disease. Nevertheless, it is not possible to 
guarantee that the species studied in this study act as 
late colonizers in rats because our results are limited to 
only one time point. However, it is essential to mention 
that the bacteria that were studied were probably not in 
the sites before the ligatures were placed. According to 
Duarte et al.,6 none of the 40 species investigated in their 
research using checkerboard DNA–DNA hybridization, 
including those investigated in the present study, were 
detected in the sulcus of unligated teeth. Although 
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rats are not natural hosts for many human bacteria, an 
exception to this general principle is infection with A. 
actinomycetemcomitans, which may naturally colonize 
the oral cavity of rats 35. On the other hand, although P. 
gingivalis colonization has been described as not being 
abundantly present in the ligature model in rats,6 previous 
researchers reported that A. actinomycetemcomitans and 
P. gingivalis were found in ligature samples after 7 days 
of experimental periodontitis induction in rats, which 
agrees with our data 36.
Concerning the experimental periodontitis model 
used in the present study, it is important to highlight 
that numerous experiments demonstrated the loss of 
periodontal attachment and the resorption of alveolar 
bone occurring predictably in a 7-day period in rats37, 
even though some investigations have been conducted 
for longer periods of time38. In the current investigation, 
the rationale for using eleven days as the experimental 
period was based on previous research that revealed 
that the application of this model of periodontitis 
induction can be recommended for only short periods 
(less than 15 days)23. Previous publications from our 
research group used this period of ligature (11 days), 
which agreed with the model used in the current 
investigation and demonstrated that the evaluated 
substances were able to promote advantages in alveolar 
bone loss and host immune-inflammatory response15. 
Importantly, the therapies were administered during 
30 days, for 19 days before periodontitis induction 
and for another 11 days following ligature placement. 
Regarding microbial analysis, it should be highlighted 
that our study used a quantitative PCR technique 
that allowed for the detection of 103 cells. In a probe 
hybridization technique, as performed in the study by 
Duarte et al.6 study, the lower limit is usually 105, with 
samples considered to be negative in the presence of 
some pathogens if this threshold is not achieved. Thus, 
from the perspective of the more sensitive technique, the 
detection of these fastidious species could be favored 
in the present investigation, which would allow for an 
adequate analysis of periodontal pathogens during the 
progression of experimental periodontitis.
A limitation of the current study could be 
attributed to the type of administration employed 
to evaluate the antimicrobial performance of 
resveratrol in diseased periodontal tissues. Future 
research is needed to determine the microbiological 
impact of the local application of resveratrol, instead 
of its systemic use, on periodontal pathogens 
because previous studies demonstrated significant 
antimicrobial outcomes with the topical application 
of resveratrol in other infectious conditions.26,27 
In addition, although different dosages and exposure 
times for resveratrol may provide additional effects 
for this substance on periodontal pathogens during 
experimental periodontitis in rats, the protocol 
employed in the current study was based on 
previous experiments using different animal 
models that demonstrated advantages for using 
resveratrol following this protocol.8,13,14,24
It is important to mention that no sample size 
calculation was performed in the present study, and 
the sample size was based on previous animal studies 
that also evaluated the effects of different substances 
on the progression of experimental periodontitis 
in rats.15,23,38. It may be hypothesized that a higher 
sample size could provide different outcomes and 
lead to significance for microbiological results during 
experimental periodontitis in rats.
Within the limitations of this investigation, it was 
demonstrated that the continuous use of resveratrol did 
not promote additional benefits in the microbiological 
outcomes of experimental periodontitis in rats, although a 
trend toward to the reduction of A. actinomycetemcomitans 
was observed in the rats that received resveratrol. 
Considering the previous data from the literature 
and the findings of the present study, the promising 
effects of resveratrol to reduce periodontal breakdown 
seem to be mediated mainly by its modulatory role in 
the immune-inflammatory response more than by its 
inhibitory effect on the periodontal pathogens. Taking 
into account the paradigm of periodontitis, periodontal 
pathogens are necessary for disease, although the 
magnitude and severity of periodontal damage are 
dependent on the individual host immune-inflammatory 
response to the bacterial challenge. Most of the therapeutic 
substances proposed as adjunctive to periodontal 
therapy have antibiotic properties or anti-inflammatory 
action. The employment of therapeutic strategies 
linking both the antibacterial and host-modulatory 
effects would improve the possibility of effectively 
treating periodontitis. 
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Conclusion
This study demonstrated that resveratrol does not 
promote benefits for microbiological outcomes of an 
experimental model of periodontitis, which suggests there 
are other mechanisms through which this substance 
exerts its promising effects to control periodontitis. 
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